Contract W81K0025FA195
Novartis Pharmaceuticals Corporation · Department Of Defense · August 18, 2025
Novartis Pharmaceuticals Corporation was awarded a federal contract by Department Of Defense (Department Of The Army) on August 18, 2025 for $3.18 million of work in pharmaceutical preparation manufacturing. Performance is in San Antonio, TX. This is a task or delivery order issued under parent IDIQ W81K0024D0004. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 8, 2025.
Contract details
- PIID
- W81K0025FA195
- Parent IDIQ
- W81K0024D0004
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Not Competed
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- San Antonio, TX
- First action
- August 18, 2025
- Latest action
- December 8, 2025
Description
LUTATHERA AND PLUVICTO - FY26 FUNDING FOR CLINS 0001 AND 0002 FOR POP DATE FROM 1OCT25 TO 30 SEPT 26.
Modification timeline
-
December 8, 2025Mod P00002 · Funding Only Action$3.23M
-
December 4, 2025Mod P00001 · Other Administrative ActionLUTATHERA AND PLUVICTO$3.23M
-
August 18, 2025Base awardLUTATHERA AND PLUVICTO$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $51 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $91 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $32 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $1.1K |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $22 |
| Cardinal Health, Inc. | Department Of Defense | December 31, 2025 | $23 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W81K0025FA195?
Contract W81K0025FA195 is a federal contract awarded to Novartis Pharmaceuticals Corporation by Department Of Defense on August 18, 2025 for $3.18 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract W81K0025FA195?
Novartis Pharmaceuticals Corporation won contract W81K0025FA195 from Department Of Defense.
How much is contract W81K0025FA195 worth?
Contract W81K0025FA195 has obligated $3.18 million to date, with a total potential value of $3.23 million if all options are exercised.